These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1030093)

  • 1. [Studies on the pharmacokinetics of digoxin in patients with hyperthyroidism].
    Gilfrich HJ
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1726-8. PubMed ID: 1030093
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacokinetics of digoxin in patients with manifest hyperthyroidism and after normalization of thyroid function.
    Bonelli J; Haydl H; Hruby K; Kaik G
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):302-6. PubMed ID: 669876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on pharmacokinetics of digoxin in hyperthyroid and hypothyroid dogs].
    Wakamatsu Y; Ogawa K
    Jpn Circ J; 1982 Nov; 46 Suppl 3():501-9. PubMed ID: 7131718
    [No Abstract]   [Full Text] [Related]  

  • 4. Digoxin kinetics in patients with thyroid dysfunction.
    Lawrence JR; Sumner DJ; Kalk WJ; Ratcliffe WA; Whiting B; Gray K; Lindsay M
    Clin Pharmacol Ther; 1977 Jul; 22(1):7-13. PubMed ID: 872497
    [No Abstract]   [Full Text] [Related]  

  • 5. Digoxin pharmacokinetics and dosage requirements in pediatric patients.
    Bendayan R; McKenzie MW
    Clin Pharm; 1983; 2(3):224-35. PubMed ID: 6349908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of nifedipine and digoxin co-administration.
    Koren G; Zylber-Katz E; Granit L; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):39-42. PubMed ID: 3957488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absorption and secretion of digoxin in soft gelatin capsules in hyperthyroidism].
    Longhini C; Portaluppi F; Alvisi V; Toselli T; Pavani F; Fersini C
    Boll Soc Ital Cardiol; 1978; 23(6):995-9. PubMed ID: 261885
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum levels and kinetics of digoxin in patients with hyperthyroidism (author's transl)].
    Gaita F; Bocchiardo M; Brossa C; Molinatti GM; Rosettani E; Brusca A
    G Ital Cardiol; 1980; 10(7):836-42. PubMed ID: 7461331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of digoxin in hyperthryoid patients.
    Koup JR
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):236. PubMed ID: 7390673
    [No Abstract]   [Full Text] [Related]  

  • 10. Extrarenal clearance, distribution volume, and elimination rate of digoxin and metildigoxin in anuric patients.
    Twittenhoff WD; Strauch M; Kütemeyer M; Koch K; Schaumann W
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):405-8. PubMed ID: 7298247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease.
    Doherty JE; Perkins WH
    Ann Intern Med; 1966 Mar; 64(3):489-507. PubMed ID: 4159745
    [No Abstract]   [Full Text] [Related]  

  • 12. Digoxin in hyperthyroidism.
    Huffman DH; Klaassen CD; Hartman CR
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):533-8. PubMed ID: 913019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Letter: Kinetics of elimination and dosage of digoxin in patients with kidney failure].
    Risler T
    Dtsch Med Wochenschr; 1974 Oct; 99(42):2130-1. PubMed ID: 4426236
    [No Abstract]   [Full Text] [Related]  

  • 14. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
    Rameis H
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of phenazone as an indicator of the metabolic capacity of the liver in patients with hyperthyroidism].
    Orzechowska-Juzwenko K; Bolanowski M; Gruszka S; Szymczak J
    Pol Tyg Lek; 1983 May 16-23; 38(20-21):643-5. PubMed ID: 6647129
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged digoxin elimination in two patients with renal and hepatic disease.
    Sorkness R
    Clin Pharm; 1983; 2(3):271-3. PubMed ID: 6883956
    [No Abstract]   [Full Text] [Related]  

  • 18. Absorption and elimination kinetics of digoxin after multiple oral doses.
    Hsieh YY; Huang JD; Lin FL; Chen RR; Lin MS; Hsu KL; Chen JH; Wu TL; Su CT; Hsu JC
    Taiwan Yi Xue Hui Za Zhi; 1983 Dec; 82(12):1269-78. PubMed ID: 6585473
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in metildigoxin pharmacokinetics in cirrhosis of the liver: a comparison with beta-acetyldigoxin.
    Rameis H; Woodcock B; Bonelli J; Waginger H
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):145-51. PubMed ID: 6715083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Digoxin pharmacokinetics in right-ventricular circulatory insufficiency].
    Halawa B; Mazurek W; Kasprzak-Wójtowicz J
    Pol Tyg Lek; 1980 Aug; 35(32):1209-12. PubMed ID: 7433202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.